Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Imaging immunity in patients with cancer using positron emission tomography.
Hegi-Johnson F, Rudd S, Hicks RJ, De Ruysscher D, Trapani JA, John T, Donnelly P, Blyth B, Hanna G, Everitt S, Roselt P, MacManus MP. Hegi-Johnson F, et al. Among authors: rudd s. NPJ Precis Oncol. 2022 Apr 7;6(1):24. doi: 10.1038/s41698-022-00263-x. NPJ Precis Oncol. 2022. PMID: 35393508 Free PMC article. Review.
Bivalent Inhibitors of Prostate-Specific Membrane Antigen Conjugated to Desferrioxamine B Squaramide Labeled with Zirconium-89 or Gallium-68 for Diagnostic Imaging of Prostate Cancer.
Noor A, Van Zuylekom JK, Rudd SE, Waldeck K, Roselt PD, Haskali MB, Wheatcroft MP, Yan E, Hicks RJ, Cullinane C, Donnelly PS. Noor A, et al. Among authors: rudd se. J Med Chem. 2020 Sep 10;63(17):9258-9270. doi: 10.1021/acs.jmedchem.0c00291. Epub 2020 Aug 13. J Med Chem. 2020. PMID: 32786229
Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models.
Liapis V, Tieu W, Wittwer NL, Gargett T, Evdokiou A, Takhar P, Rudd SE, Donnelly PS, Brown MP, Staudacher AH. Liapis V, et al. Among authors: rudd se. Mol Imaging Biol. 2021 Dec;23(6):914-928. doi: 10.1007/s11307-021-01620-1. Epub 2021 Jul 6. Mol Imaging Biol. 2021. PMID: 34231102 Free PMC article.
Correction to: Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models.
Liapis V, Tieu W, Wittwer NL, Gargett T, Evdokiou A, Takhar P, Rudd SE, Donnelly PS, Brown MP, Staudacher AH. Liapis V, et al. Among authors: rudd se. Mol Imaging Biol. 2021 Dec;23(6):929. doi: 10.1007/s11307-021-01640-x. Mol Imaging Biol. 2021. PMID: 34398402 Free PMC article. No abstract available.
ImmunoPET: IMaging of cancer imMUNOtherapy targets with positron Emission Tomography: a phase 0/1 study characterising PD-L1 with 89Zr-durvalumab (MEDI4736) PET/CT in stage III NSCLC patients receiving chemoradiation study protocol.
Hegi-Johnson F, Rudd SE, Wichmann C, Akhurst T, Roselt P, Trinh J, John T, Devereux L, Donnelly PS, Hicks R, Scott AM, Steinfort D, Fox S, Blyth B, Parakh S, Hanna GG, Callahan J, Burbury K, MacManus M. Hegi-Johnson F, et al. Among authors: rudd se. BMJ Open. 2022 Nov 18;12(11):e056708. doi: 10.1136/bmjopen-2021-056708. BMJ Open. 2022. PMID: 36400733 Free PMC article. Clinical Trial.
153 results